Rock Creek Advisors (the “Sale Agent”) is contacting you regarding Exeevo, Inc. (the “Company” or “Exeevo”). In parallel with other initiatives, we are helping the company evaluate strategic alternatives, which may include, but are not limited to an asset sale of the operating business, all associated IP, trademarks, partnerships and licenses.
Exeevo is a top 3, global AI-powered cloud solutions provider player in the Life Sciences software market. The Company was founded in 2017 as a result of a strategic partnership between Indegene and Microsoft.
It is the only Company that combines sales management, customer insight journeys, and patient engagement in a single Customer Experience (“CX”) platform. Its solutions enhance customer interactions, drive commercial goals, and improve patient outcomes for Pharma, Consumer, Healthcare and Life Sciences companies.
Key Investment Highlights
· Global Market Leadership: Exeevo is the only player that seamlessly integrates sales, marketing, and patient engagement on one platform, making it a top 3 CX software provider in Life Sciences.
· Strategic Partnership with Microsoft: The Company’s unique partnership with Microsoft provides early access to the latest AI capabilities and technological improvements, positioning Exeevo strongly against industry incumbents.
· Expansive Market Opportunity: With a total addressable market of $19B, there is significant potential for growth as Life Sciences organizations increasingly digitize their customer experiences.
· Validation by Industry Leaders: Exeevo’s solutions are validated and deployed by leading global pharma and medtech organizations across all major markets.
· Growth Potential: Exeevo is poised for expansion within its existing customer base and other Fortune 500 Life Science companies globally.
· Robust Financial Profile: Exeevo’s per-user-per-month recurring revenue model has shown a 69% CAGR over the past three years, with an installed base capable of generating up to $32M in annual recurring revenue (ARR) at full deployment and $224M ARR potential with its current pipeline.
See Teaser and SEC filings links below for information on the Company, its platform, products, and leadership team.
Rock Creek will consider all types of interest.
We require an executed Confidentiality Agreement (see NDA link below) to provide access to a Confidential electronic data room with more Company information. If there is another person at your firm who would be more appropriate to review this matter, please let us know and/or forward this information accordingly. Also, if your firm is not interested in pursuing this opportunity, we’d appreciate knowing in order not to continue to follow up with you.